Hepaxa Management of Non-alcoholic Fatty Liver Disease

Inclusion Criteria: 1. Men or women, ≥18 years of age. 2. Suspicion of NAFLD 3. Able to understand and cooperate with study procedures, and have signed a written informed consent prior to any study procedures. 4. CAP score at -6 months and at inclusion of \>268 5. A fibroscan elastography score \<9 Kpa (Advanced Fibrosis) Exclusion Criteria: 1. Other causes of liver inflammation including Hepatitis A, B or C, HIV, confirmed or suspected cirrhosis, Wilson's disease, autoimmune hepatitis, hemochromatosis, alcoholic steatohepatitis, pancreatitis, or prescription medications known to cause liver damage, or known to be hepatotoxic. 2. Significant weight loss (\> 5% body weight) or rapid weight loss (\>1.6 kg/week), within six months of screening. 3. Individuals taking prescription or supplemental omega-3 fatty acids. 4. Has a condition the Investigator believes would interfere with the evaluation of the subject, or may put the subject at undue risk during the course of the study, including potentially abnormal lab results, due to a traumatic event.